These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2997764)

  • 1. Microcrystalline hydroxyapatite compound in prevention of bone loss in corticosteroid-treated patients with chronic active hepatitis.
    Stellon A; Davies A; Webb A; Williams R
    Postgrad Med J; 1985 Sep; 61(719):791-6. PubMed ID: 2997764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy.
    Stellon AJ; Davies A; Compston J; Williams R
    Gastroenterology; 1985 Nov; 89(5):1078-83. PubMed ID: 4043665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial of microcrystalline hydroxyapatite compound ('Ossopan') in the prevention of osteoporosis due to corticosteroid therapy.
    Pines A; Raafat H; Lynn AH; Whittington J
    Curr Med Res Opin; 1984; 8(10):734-42. PubMed ID: 6373153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis.
    Stellon AJ; Webb A; Compston JE
    Gut; 1988 Mar; 29(3):378-84. PubMed ID: 3356370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss.
    Mitchison HC; Bassendine MF; Malcolm AJ; Watson AJ; Record CO; James OF
    Hepatology; 1989 Oct; 10(4):420-9. PubMed ID: 2777203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium metabolism in bone disease: effects of treatment with microcrystalline calcium hydroxyapatite compound and dihydrotachysterol.
    Dent CE; Davies IJ
    J R Soc Med; 1980 Nov; 73(11):780-5. PubMed ID: 6264079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study.
    Chesnut CH; Majumdar S; Newitt DC; Shields A; Van Pelt J; Laschansky E; Azria M; Kriegman A; Olson M; Eriksen EF; Mindeholm L
    J Bone Miner Res; 2005 Sep; 20(9):1548-61. PubMed ID: 16059627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Backfilling of iliac crest defects with hydroxyapatite-calcium triphosphate biphasic compound: a prospective, randomized computed tomography and patient-based analysis.
    Burton DC; Carlson BB; Johnson PL; Manna BJ; Riazi-Kermani M; Glattes RC; Jackson RS
    Spine J; 2013 Jan; 13(1):54-61. PubMed ID: 23168135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.
    Lam KC; Lai CL; Trepo C; Wu PC
    N Engl J Med; 1981 Feb; 304(7):380-6. PubMed ID: 7005678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vertebral fracture and cortical bone changes in corticosteroid-induced osteoporosis.
    Tsugeno H; Tsugeno H; Fujita T; Goto B; Sugishita T; Hosaki Y; Ashida K; Mitsunobu F; Tanizaki Y; Shiratori Y
    Osteoporos Int; 2002 Aug; 13(8):650-6. PubMed ID: 12181624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effect of nandrolone decanoate, 1 alpha-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study.
    Geusens P; Dequeker J
    Bone Miner; 1986 Sep; 1(4):347-57. PubMed ID: 3333018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study on bone mineral mass in metabolic bone disorders--I-125 photon absorptiometry].
    Kishimoto H
    Nihon Seikeigeka Gakkai Zasshi; 1983 Nov; 57(11):1699-715. PubMed ID: 6676388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone lesions following renal transplantation. Bone mineral density and amount of trabecular bone.
    Nielsen HE; Melsen F; Christensen MS
    Scand J Urol Nephrol Suppl; 1977; (42):127-9. PubMed ID: 356191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects on the bones of nandrolone decanoate therapy in postmenopausal osteoporosis].
    Gennari C; Agnusdei D; Gonnelli S
    Minerva Endocrinol; 1989; 14(1):69-74. PubMed ID: 2659955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid-induced fractures and bone loss in patients with asthma.
    Adinoff AD; Hollister JR
    N Engl J Med; 1983 Aug; 309(5):265-8. PubMed ID: 6866051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid-induced bone loss in men.
    Pearce G; Tabensky DA; Delmas PD; Baker HW; Seeman E
    J Clin Endocrinol Metab; 1998 Mar; 83(3):801-6. PubMed ID: 9506731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis.
    Storm T; Thamsborg G; Steiniche T; Genant HK; Sørensen OH
    N Engl J Med; 1990 May; 322(18):1265-71. PubMed ID: 2109197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of D-003, a mixture of very high molecular weight aliphatic acids, on prednisolone-induced osteoporosis in Sprague-Dawley rats.
    Noa M; Mendoza S; Más R; Mendoza N; León F
    Drugs R D; 2004; 5(5):281-90. PubMed ID: 15357627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term decomposition of bones. 1. Mineral phase].
    Herrmann B; Newesely H
    Anthropol Anz; 1982 Mar; 40(1):19-31. PubMed ID: 6285805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis in chronic cholestatic liver disease.
    Stellon AJ; Davies A; Compston J; Williams R
    Q J Med; 1985 Nov; 57(223):783-90. PubMed ID: 2934760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.